Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Medpace Holdings, Inc. (MEDP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Carley Brian T (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Exercised 103 restricted stock units
@ $0 |
|
| 10/03/2023 |
4
| Kraft Robert O. (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Exercised 94 restricted stock units
@ $0 |
|
| 10/03/2023 |
4
| McCarthy Cornelius P. III (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Exercised 82 restricted stock units
@ $0 |
|
| 08/16/2023 |
4
| Kraft Robert O. (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Sold 13,782 shares
@ $265.67, valued at
$3.7M
Exercised 13,782 options to buy
@ $26.44, valued at
$364.4k
|
|
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
4
| Brady Kevin M. (CFO & Treasurer) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Sold 7,000 shares
@ $255, valued at
$1.8M
Exercised 10,000 options to buy
@ $90.65, valued at
$906.5k
|
|
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/25/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/24/2023 |
8-K
| Quarterly results |
| 07/05/2023 |
4
| Kraft Robert O. (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Exercised 94 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| McCarthy Cornelius P. III (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Exercised 82 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| Carley Brian T (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Exercised 103 restricted stock units
@ $0 |
|
| 06/12/2023 |
4
| Troendle August J. (CEO) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Sold 49,347 shares
@ $220.85, valued at
$10.9M
|
|
| 06/12/2023 |
4
| Medpace Investors, LLC (10% Owner) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Sold 49,347 shares
@ $220.85, valued at
$10.9M
|
|
| 06/08/2023 |
4
| Troendle August J. (CEO) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Sold 58,681 shares
@ $220.46, valued at
$12.9M
Sold 110,324 shares
@ $223.05, valued at
$24.6M
|
|
| 06/08/2023 |
4
| Medpace Investors, LLC (10% Owner) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Sold 58,681 shares
@ $220.46, valued at
$12.9M
Sold 110,324 shares
@ $223.05, valued at
$24.6M
|
|
| 06/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/23/2023 |
4
| Carley Brian T (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Granted 1,769 options to buy
@ $210.88, valued at
$373k
|
|
| 05/23/2023 |
4
| DAVENPORT FRED B JR (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Granted 1,769 options to buy
@ $210.88, valued at
$373k
|
|
| 05/23/2023 |
4
| Gwadry-Sridhar Femida H. (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Granted 1,769 options to buy
@ $210.88, valued at
$373k
|
|
| 05/23/2023 |
4
| Keating Ashley M. (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Granted 1,769 options to buy
@ $210.88, valued at
$373k
|
|
| 05/23/2023 |
4
| McCarthy Cornelius P. III (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Granted 1,769 options to buy
@ $210.88, valued at
$373k
|
|
| 05/23/2023 |
4
| Kraft Robert O. (Director) has filed a Form 4 on Medpace Holdings, Inc.|
Txns:
| Granted 1,769 options to buy
@ $210.88, valued at
$373k
|
|
| 05/19/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/24/2023 |
8-K
| Quarterly results |
| 04/05/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/05/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/05/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
|
|
|